Brief: Natco Pharma Approves To Incorporate A Subsidiary Company In Indonesia
20/04/2023 06:42
April 20 (Reuters) - Natco Pharma Ltd NATP.NS :
* NATCO PHARMA LTD - APPROVED TO INCORPORATE A SUBSIDIARY
COMPANY
IN INDONESIA
* NATCO PHARMA LTD- INVESTMENT UP TO AN AMOUNT NOT EXCEEDING
US$ 3
MILLION
* NATCO PHARMA LTD- INITIALLY CO WILL INVEST US$ 1 MILLION
FOR A
STAKE OF 51%, BALANCE STAKE WILL BE HELD BY PT. MITRA MEDIS EXIM
Source text for Eikon: ID:nBSEb243Ws
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees